Certified by Founder Lodge
Flare Therapeutics
United States - Cambridge , MA
START UP
1 Disclosed Funding Rounds $123,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients.
Flare is lighting up a new therapeutic space with an entire
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 23 ,2023 | Series B | $123,000,000 |
Pfizer
Casdin Capital, LLC
ShangBay Capital
Nextech Invest
Novartis
Third Rock Ventures
Agent Capital
Eventide Asset Management
Boxer Capital, LLC
GordonMD® Global Investments LP
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
